Ncardia
Founded 2011 · 42 employees on LinkedIn · 1 known investors
Find your way into Ncardia
270 people in our graph share verified history with the Ncardia team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Stefan Braam · together at Utrecht University (overlapped)
×4knows the team · via Nyenrode Business University
knows the team · via Saxion University of Applied Sciences
×5knows the team · via Utrecht University
knows the team · via Global Shapers Community
Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.
Founders & leadership
Ncardia was founded in 2011 by Stefan Braam, Prof. Dr. Mummery, and Prof. Dr. Passier.
SB
Stefan BraaminCo-founder & Chief Technical OfficerStefan Braam holds an MSc and PhD in stem cell biology and has founded and led Ncardia, serving as CEO and co-founder where he was a key inventor of the core iPSC technologies. He has worked as a researcher in the UK and Australia, and holds multiple patents in stem cell technology.
PD
Prof. Dr. Mummery
PD
Prof. Dr. Passier
HS
Herman Spolders
JC
Jason ConnerinChief Executive Officer
JD
Jeroen de GrootinChief Operation Officer Early Discovery
Investors · 1
Founder mafia
2 people who came through Ncardia went on to found or lead other companies.
In the news
Frequently asked questions
- What does Ncardia do?
- Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.
- Who founded Ncardia?
- Ncardia was founded by Stefan Braam, Prof. Dr. Mummery, Prof. Dr. Passier in 2011.
- Who are Ncardia's investors?
- Ncardia's investors include Vesalius Biocapital Partners.